Capital International Investors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,522,786
| Closed | -$42.6M | – | 451 |
|
|
2024
Q2 | $42.6M | Sell |
1,522,786
-1,232,625
| -45% | -$33.9M | 0.01% | 329 |
|
|
2024
Q1 | $76.5M | Sell |
2,755,411
-9,021,919
| -77% | -$250M | 0.02% | 297 |
|
|
2023
Q4 | $339M | Sell |
11,777,330
-5,160,926
| -30% | -$156M | 0.08% | 189 |
|
|
2023
Q3 | $562M | Sell |
16,938,256
-11,706,423
| -41% | -$414M | 0.14% | 145 |
|
|
2023
Q2 | $1.05B | Sell |
28,644,679
-27,358,256
| -49% | -$1.06B | 0.25% | 100 |
|
|
2023
Q1 | $2.28B | Sell |
56,002,935
-2,302,688
| -4% | -$99.5M | 0.59% | 44 |
|
|
2022
Q4 | $2.99B | Buy |
58,305,623
+2,981,745
| +5% | +$143M | 0.8% | 27 |
|
|
2022
Q3 | $2.42B | Buy |
55,323,878
+5,892,896
| +12% | +$286M | 0.71% | 35 |
|
|
2022
Q2 | $2.59B | Buy |
49,430,982
+10,900,979
| +28% | +$556M | 0.7% | 37 |
|
|
2022
Q1 | $1.99B | Buy |
38,530,003
+37,310,556
| +3,060% | +$1.94B | 0.45% | 56 |
|
|
2021
Q4 | $72M | Sell |
1,219,447
-630
| -0.1% | -$31.2K | 0.02% | 338 |
|
|
2021
Q3 | $52.5M | Buy |
1,220,077
+584
| +0% | +$25.9K | 0.01% | 346 |
|
|
2021
Q2 | $47.8M | Hold |
1,219,493
| – | – | 0.01% | 364 |
|
|
2021
Q1 | $44.2M | Sell |
1,219,493
-4,389,239
| -78% | -$156M | 0.01% | 345 |
|
|
2020
Q4 | $206M | Sell |
5,608,732
-298,453
| -5% | -$10.9M | 0.06% | 232 |
|
|
2020
Q3 | $206M | Sell |
5,907,185
-807,224
| -12% | -$28.3M | 0.06% | 221 |
|
|
2020
Q2 | $208M | Sell |
6,714,409
-1,954,730
| -23% | -$66.4M | 0.07% | 206 |
|
|
2020
Q1 | $268M | Sell |
8,669,139
-14,527,538
| -63% | -$495M | 0.11% | 152 |
|
|
2019
Q4 | $862M | Sell |
23,196,677
-10,687,106
| -32% | -$381M | 0.29% | 102 |
|
|
2019
Q3 | $1.16B | Buy |
33,883,783
+402,261
| +1% | +$14.6M | 0.44% | 67 |
|
|
2019
Q2 | $1.38B | Buy |
33,481,522
+214,098
| +0.6% | +$8.5M | 0.55% | 47 |
|
|
2019
Q1 | $1.34B | Buy |
33,267,424
+1,188,902
| +4% | +$47.6M | 0.58% | 49 |
|
|
2018
Q4 | $1.33B | Sell |
32,078,522
-1,271,776
| -4% | -$52.8M | 0.66% | 43 |
|
|
2018
Q3 | $1.39B | Buy |
33,350,298
+78,233
| +0.2% | +$3.01M | 0.64% | 41 |
|
|
2018
Q2 | $1.15B | Buy |
33,272,065
+1,074,841
| +3% | +$36.7M | 1.29% | 19 |
|
|
2018
Q1 | $1.08B | Buy |
32,197,224
+2,754,260
| +9% | +$94.7M | 1.25% | 18 |
|
|
2017
Q4 | $1.01B | Sell |
29,442,964
-4,270,281
| -13% | -$146M | 1.14% | 23 |
|
|
2017
Q3 | $1.14B | Sell |
33,713,245
-6,092,331
| -15% | -$196M | 1.37% | 18 |
|
|
2017
Q2 | $1.27B | Sell |
39,805,576
-16
| -0% | -$505 | 1.69% | 9 |
|
|
2017
Q1 | $1.29B | Buy |
39,805,592
+1,159,715
| +3% | +$36.6M | 1.76% | 8 |
|
|
2016
Q4 | $1.19B | Sell |
38,645,877
-3,179,733
| -8% | -$97.1M | 1.72% | 10 |
|
|
2016
Q3 | $1.34B | Buy |
41,825,610
+271,733
| +0.7% | +$9.09M | 1.95% | 7 |
|
|
2016
Q2 | $1.39B | Buy |
41,553,877
+3,006,535
| +8% | +$96M | 2.04% | 6 |
|
|
2016
Q1 | $1.08B | Buy |
38,547,342
+7,477,128
| +24% | +$214M | 1.66% | 7 |
|
|
2015
Q4 | $952M | Buy |
31,070,214
+7,649,722
| +33% | +$241M | 1.47% | 11 |
|
|
2015
Q3 | $698M | Sell |
23,420,492
-1,153,445
| -5% | -$37M | 1.27% | 14 |
|
|
2015
Q2 | $782M | Buy |
24,573,937
+27,088
| +0.1% | +$883K | 1.33% | 14 |
|
|
2015
Q1 | $810M | Buy |
24,546,849
+7,593,016
| +45% | +$241M | 1.47% | 14 |
|
|
2014
Q4 | $501M | Sell |
16,953,833
-1,140,924
| -6% | -$32.7M | 1.02% | 26 |
|
|
2014
Q3 | $508M | Buy |
18,094,757
+13,228
| +0.1% | +$371K | 1.24% | 15 |
|
|
2014
Q2 | $509M | Sell |
18,081,529
-721,569
| -4% | -$20.6M | 1.32% | 15 |
|
|
2014
Q1 | $573M | Buy |
18,803,098
+1,439,554
| +8% | +$42.9M | 1.54% | 13 |
|
|
2013
Q4 | $505M | Buy |
17,363,544
+7,689,035
| +79% | +$224M | 1.57% | 11 |
|
|
2013
Q3 | $264M | Hold |
9,674,509
| – | – | 1.13% | 17 |
|
|
2013
Q2 | $257M | Buy |
+9,674,509
| New | +$267M | 1.17% | 15 |
|
Other funds holding PFE
Capital International Investors's PFE Position: Q3 2024 in Review
Capital International Investors sold out of Pfizer (PFE) in Q3 2024, closing a stake of 1,522,786 shares — an estimated $42.6M sold.
Capital International Investors first reported a position in PFE in Q2 2013 and held it in 45 quarters. The position peaked at $2.99B in Q4 2022. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- Capital International Investors reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
- Capital International Investors sold 1,522,786 Pfizer shares in Q3 2024, an estimated $42.6M.
- Capital International Investors first reported a position in Pfizer in Q2 2013 and held it in 45 quarters.
- Capital International Investors's Pfizer position peaked at $2.99B in Q4 2022.
- 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on Capital International Investors's 13F filing for Q3 2024, filed 13 Nov 2024.